It is possible that the prolonged action of galanin can reflect its internalization in the target cells and/or a formation of galanin fragments which have prolonged action in vivo (Schött et al. 1998; Jansson et al. 2000).
It could be predicted that the established DNA-PLA-PEG-NPs with a delayed release effect could keep the loaded DNA prolonged action in vivo.
This is concordant with the major requirement for nickel carcinogenicity, which is prolonged action on the target tissue.
In addition, one major requirement for Ni II) carcinogenicity is prolonged action on the target tissue (Kasprzak et al. 2003), which is typical of tumor promoters acting through epigenetic mechanisms, rather than tumor initiators, which are mutagenic.
Moreover, ranolazine reversed abnormalities of repolarization (prolonged action potential duration, beat-to-beat variability, and dispersion of action potential duration and early afterdepolarizations) of ventricular myocytes from failing canine hearts [ 22].
This increase in NCX forward mode displays the link between ranolazine-modulated cytosolic Na and Ca in such a way that both stimuli of the reverse NCX mode in heart failure, elevated [Na]i and prolonged action potential duration, become attenuated by exposure to ranolazine, leading to improved Ca elimination during diastole.
Although both nanostructures showed prolonged action profiles and improved serum stability compared to the parent peptide, the morphology of the nanostructures is highly critical to manipulate the release profile of the free peptide from the assembly and regulate their bioactivity.
Applied at a concentration of 1 µM, the TRPC3 activator transiently but significantly (P < 0.05) prolonged action potential duration (APD90) in TRPC3-overexpressing myocytes from 29.5 ± 5.6 to 53.0 ± 9.0 ms as shown in Figure 1 C and moderately depolarized cells from −75.2 ± 1.3 to −71.7 ± 2.2 mV (P < 0.05, tested by unpaired t-test).
Results: Cardiac BPA exposure resulted in prolonged PR segment and decreased epicardial conduction velocity (0.1 100 μM BPA), prolonged action potential duration (1 100 μM BPA), and delayed atrioventricular conduction (10 100 μM BPA).
Advances in ocular drug delivery system research are expected to provide new tools for the treatment of posterior segment diseases, providing improved drug penetration, prolonged action, higher efficacy, improved safety and less invasive administration, resulting in higher patient compliance.
Pharmacological studies using 4-aminopyridine showed that prolonged action potential duration and reduced maximum capture rate in tissue constructs as compared with native ventricles could be explained by decreased transient outward potassium current.
